This article has been updated with information from Roche's earnings presentation.

NEW YORK (GenomeWeb) – Roche today reported that its 2016 diagnostics revenues grew 6 percent year over year, driven by strong immunodiagnostics product sales within its centralized and point-of-care solutions business.

The company reported CHF 50.58 billion ($51.09 billion) in 2016 revenues, up 5 percent from CHF 48.15 billion in 2015. At constant exchange rates, the firm's revenues grew 4 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.